Results 21 to 30 of about 31,515 (266)

Efficacy and Safety Assessment of Antifungal Prophylaxis with Posaconazole Using Therapeutic Drug Monitoring in Pediatric Patients with Oncohematological Disorders-A Single-Centre Study. [PDF]

J Fungi (Basel)
Liszka K, Marschollek P, Przystupski D, Frączkiewicz J, Mielcarek-Siedziuk M, Olejnik I, Gamrot Z, Haze N, Kwella A, Zalewska P, Resztak M, Ussowicz M, Kałwak K.   +12 more
europepmc   +3 more sources

Nebulized Amphotericin B in Mechanically Ventilated COVID-19 Patients to Prevent Invasive Pulmonary Aspergillosis: A Retrospective Cohort Study

Critical Care Explorations, 2022
IMPORTANCE:. Despite high mortality rates of COVID-19-associated pulmonary aspergillosis (CAPA) in the ICU, antifungal prophylaxis remains a subject of debate.
Max Melchers, MD, Arthur R. H. van Zanten, MD, PhD, Moniek Heusinkveld, MD, PhD, Jan Willem Leeuwis, MD, PhD, Roel Schellaars, MD, Hendrick J. W. Lammers, MSc, Freek J. Kreemer, MD, Pieter-Jan Haas, MD, PhD, Paul E. Verweij, MD, PhD, Sjoerd H. W. van Bree, MD, PhD   +9 more
doaj   +1 more source

Primary Mold-Active Antifungal Prophylaxis Decreases the Need for Chest Computed Tomography Scans in Patients with Acute Lymphoblastic Leukemia. [PDF]

Indian J Hematol Blood Transfus, 2023
Karadaş N, Özdemir HH, Yilmaz Y, Göktepe ŞÖ, Ece D, Karapinar DY.   +5 more
europepmc   +3 more sources

Characteristics of antifungal utilization for hospitalized children in the United States

Antimicrobial Stewardship & Healthcare Epidemiology, 2022
Objective: To characterize antifungal prescribing patterns, including the indication for antifungal use, in hospitalized children across the United States.
Lourdes Eguiguren, Brian R. Lee, Jason G. Newland, Matthew P. Kronman, Adam L. Hersh, Jeffrey S. Gerber, Grace M. Lee, Hayden T. Schwenk   +7 more
doaj   +1 more source

Treatment of Primary Pulmonary Aspergillosis: An Assessment of the Evidence. [PDF]

, 2016
Aspergillus spp. are a group of filamentous molds that were first described due to a perceived similarity to an aspergillum, or liturgical device used to sprinkle holy water, when viewed under a microscope.
Stewart, Ethan R, Thompson, George R
core   +5 more sources

Antifungal prophylaxis with azole derivatives [PDF]

Clinical Microbiology and Infection, 2004
In recent years, several reports have underlined the increasing role of fungal infections as a cause of morbidity and mortality in hospitalised patients. For this reason, and also in light of the high mortality rate associated with these infections, chemoprophylaxis has been advocated by several authors.
CASTAGNOLA E, MACHETTI M, BUCCI B, VISCOLI, CLAUDIO   +3 more
openaire   +3 more sources

Systemic antifungal strategies in allogeneic hematopoietic stem cell recipients hospitalized in french hematology units: a post-hoc analysis of the cross-sectional observational AFHEM study

BMC Infectious Diseases, 2022
Background Invasive fungal diseases (IFD) remain a major complication of allogeneic hematopoietic stem cell transplantation (alloHSCT) and are associated with high mortality rates in patients receiving alloHSCT.
Mauricette Michallet, Jean El Cheikh, Raoul Herbrecht, Ibrahim Yakoub-Agha, Denis Caillot, Jean-Pierre Gangneux   +5 more
doaj   +1 more source

Histoplasma capsulatum Infection in an Allogeneic Hematopoietic Stem Cell Transplant Patient Receiving Voriconazole Prophylaxis [PDF]

, 2020
Histoplasma capsulatum infection is a rare complication in the allogeneic stem cell transplant patients. Minimal guidance exists on how to appropriately manage histoplasmosis in these patients.
Agrawal, Vaibhav, Brinda, Bryan J., Farag, Sherif S.   +2 more
core   +1 more source

Intensive care unit-related fluconazole use in Spain and Germany: patient characteristics and outcomes of a prospective multicenter longitudinal observational study [PDF]

, 2013
Background: Candida spp. are a frequent cause of nosocomial bloodstream infections worldwide. Objective: To evaluate the use patterns and outcomes associated with intravenous (IV) fluconazole therapy in intensive care units in Spain and Germany ...
Ballus, Jose, Bingold, Tobias Michael, Kaskel, Peter, Krobot, Karl J., Kumar, Ritesh N., Mavros, Panagiotis, Nocea, Gonzalo, Wissing, Heimo   +7 more
core   +1 more source

Antifungal prophylaxis of patients undergoing allogenetic hematopoietic stem cell transplantation in China: a multicenter prospective observational study

Journal of Hematology & Oncology, 2016
Background Antifungal prophylaxis is currently regarded as the gold standard in situations with allo-genetic hematopoietic stem cell transplantation (allo-HSCT).
Lei Gao, Yuqian Sun, Fanyi Meng, Mingzhe Han, He Huang, Depei Wu, Li Yu, Hanyun Ren, Xiaojun Huang, Xi Zhang   +9 more
doaj   +1 more source